Therapeutic Potential of Marine-Derived Cyclic Peptides as Antiparasitic Agents
Open Access
- 25 November 2023
- journal article
- review article
- Published by MDPI AG in Marine Drugs
- Vol. 21 (12) , 609
Abstract
Parasitic diseases still compromise human health. Some of the currently available therapeutic drugs have limitations considering their adverse effects, questionable efficacy, and long treatment, which have encouraged drug resistance. There is an urgent need to find new, safe, effective, and affordable antiparasitic drugs. Marine-derived cyclic peptides have been increasingly screened as candidates for developing new drugs. Therefore, in this review, a systematic analysis of the scientific literature was performed and 25 marine-derived cyclic peptides with antiparasitic activity (1–25) were found. Antimalarial activity is the most reported (51%), followed by antileishmanial (27%) and antitrypanosomal (20%) activities. Some compounds showed promising antiparasitic activity at the nM scale, being active against various parasites. The mechanisms of action and targets for some of the compounds have been investigated, revealing different strategies against parasites.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia (UIDB/04423/2020, UIDP/04423/2020, NORTE-01-0145-FEDER-000040, PTDC/CTA-AMB/0853/2021, EXPL/CTA-AMB/0810/2021)
- COMPETE 2020 (UIDB/04423/2020, UIDP/04423/2020, NORTE-01-0145-FEDER-000040, PTDC/CTA-AMB/0853/2021, EXPL/CTA-AMB/0810/2021)
This publication has 222 references indexed in Scilit:
- Novel N -Benzoyl-2-Hydroxybenzamide Disrupts Unique Parasite Secretory PathwayAntimicrobial Agents and Chemotherapy, 2012
- Trypanosoma cruzi infection: a review with emphasis on cutaneous manifestationsInternational Journal of Dermatology, 2012
- In vitro and in vivo evaluation of select kahalalide F analogs with antitumor and antifungal activitiesBioorganic & Medicinal Chemistry, 2011
- Quinine, an old anti-malarial drug in a modern world: role in the treatment of malariaMalaria Journal, 2011
- Natural functions of lipopeptides fromBacillusandPseudomonas: more than surfactants and antibioticsFEMS Microbiology Reviews, 2010
- Chagas diseaseThe Lancet, 2010
- Dragonamide E, a Modified Linear Lipopeptide from Lyngbya majuscula with Antileishmanial ActivityJournal of Natural Products, 2009
- Artemisinin derivatives inhibit Toxoplasma gondii in vitro at multiple steps in the lytic cycleJournal of Antimicrobial Chemotherapy, 2008
- Mollamides B and C, Cyclic Hexapeptides from the Indonesian Tunicate Didemnum molleJournal of Natural Products, 2008
- Symplocamide A, a Potent Cytotoxin and Chymotrypsin Inhibitor from the Marine Cyanobacterium Symploca sp.Journal of Natural Products, 2007